StockData
Paysign, Inc. logo

Paysign, Inc. (PAYS) stock

PAYSNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 14/301% above fair value
$9.81+0.27 (+2.83%)

Close on Nov 17, 2026Market cap $553.89MP/E 37.7Yield –

Earnings

Paysign's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 23, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$30.80M
+42.6% on a year earlier
Adjusted EPS, Q3 FY2026
$0.11
$0.04 a year earlier
Latest guidance
Issued
Nov 9, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of Paysign's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 23, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close$30.80M+42.6%$0.11–Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$28.25M+48.1%$0.11$0.16Release
Q1 FY2026ended Mar 31, 2026May 12, 2026after the close$28.04M+50.8%$0.09$0.17Release
Q4 FY2025ended Dec 31, 2025Mar 24, 2026after the close$22.76M+45.8%$0.02$0.09Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025after the close$21.60M+41.5%$0.04–Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025after the close$19.08M+33.1%$0.02$0.08Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close$18.60M+40.9%$0.05$0.09Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025after the close$15.61M+13.9%$0.02$0.05Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024after the close$15.26M+23.1%$0.03$0.05Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024after the close$14.33M+30.3%$0.01$0.04Release
Q1 FY2024ended Mar 31, 2024May 7, 2024after the close$13.20M+30.7%$0.01$0.03Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Paysign's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueGAAPFY2026$114.00M – $117.00M–NewNov 9, 2026
RevenueFY2026$114.00M – $117.00M$106.50M – $110.50MRaisedAug 5, 2026
year-over-year growthFY2026+30% – +35%–NewMar 24, 2026
Gross marginFY202662% – 63%60% – 62%RaisedAug 5, 2026
Gross profit marginGAAPFY202663.5% – 64.5%–NewNov 9, 2026
Adjusted EBITDAnon-GAAPFY2026$38.50M – $40.00M–NewNov 9, 2026
Adjusted EBITDAnon-GAAPFY2026$35.00M – $38.00M$30.00M – $33.00MRaisedAug 5, 2026
Diluted EPSGAAPFY2026$0.37 – $0.38–NewNov 9, 2026
Diluted EPSGAAPFY2026$0.35 – $0.37$0.21 – $0.26RaisedAug 5, 2026
Adj. EBITDA per diluted sharenon-GAAPFY2026$0.57 – $0.61$0.49 – $0.53RaisedAug 5, 2026
depreciation and amortization expenseFY2026$9.50M – $10.00M–NewMar 24, 2026
full-year tax rateFY202622.5% – 25%–NewMar 24, 2026
fully diluted shares outstandingFY202662.3–NewMar 24, 2026
interest incomeFY2026$3.10M–LoweredMar 24, 2026
Net incomeGAAPFY2026$23.00M – $24.00M–NewNov 9, 2026
Net incomeGAAPFY2026$21.50M – $23.00M$13.00M – $16.00MRaisedAug 5, 2026
Operating expensesFY2026+20%–NewMar 24, 2026
Revenue growth (YoY)FY2026+39% – +43%–RaisedAug 5, 2026
stock-based compensationFY2026$5.50M–LoweredMar 24, 2026

Guidance vs results

The last range Paysign gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026EPS (GAAP)$0.09 – $0.10$0.11Above range
Q3 FY2026Revenue$28.50M – $30.00M$30.80MAbove range
Q1 FY2026adjusted EBITDA per share$0.15 – $0.16$0.17Above range
Q1 FY2026EPS (GAAP)$0.07 – $0.08$0.09Above range
Q1 FY2026Revenue$27.00M – $27.50M$28.04MAbove range
Q1 FY2026Revenue growth+45.2% – +47.8%+50.75%Above range
FY2025EPS (GAAP)$0.12 – $0.13$0.13Σ4QWithin range
FY2025Revenue$80.50M – $81.50M$82.04MΣ4QAbove range
Q3 FY2025Revenue$19.50M – $20.50M$21.60MAbove range
Q2 FY2025Revenue$18.50M – $19.00M$19.08MAbove range
Q1 FY2025Revenue$17.50M – $18.00M$18.60MAbove range
Q2 FY2024Revenue growth+27.5%+30.27%Above range

Guidance history

Every forecast Paysign put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026Adjusted EBITDAFY2026$38.50M – $40.00MNew
Nov 9, 2026Diluted EPSFY2026$0.37 – $0.38New
Nov 9, 2026Gross profit marginFY202663.5% – 64.5%New
Nov 9, 2026Net incomeFY2026$23.00M – $24.00MNew
Nov 9, 2026RevenueFY2026$114.00M – $117.00MNew
Aug 5, 2026Adjusted EBITDAFY2026$35.00M – $38.00MRaised
Aug 5, 2026Adjusted EBITDAQ3 FY2026$9.50M – $10.00MNew
Aug 5, 2026Adj. EBITDA per diluted shareQ3 FY2026$0.15 – $0.16New
Aug 5, 2026Adj. EBITDA per diluted shareFY2026$0.57 – $0.61Raised
Aug 5, 2026Diluted EPSFY2026$0.35 – $0.37Raised
Aug 5, 2026Diluted EPSQ3 FY2026$0.09 – $0.10New
Aug 5, 2026Gross marginQ3 FY202661% – 63%New
Aug 5, 2026Gross marginFY202662% – 63%Raised
Aug 5, 2026plasma centersQ3 FY2026561 – 563Raised
Aug 5, 2026Revenue growth (YoY)Q3 FY2026+32% – +38.9%New
Aug 5, 2026Net incomeQ3 FY2026$5.70M – $6.00MNew
Aug 5, 2026Revenue growth (YoY)FY2026+39% – +43%Raised
Aug 5, 2026Net incomeFY2026$21.50M – $23.00MRaised
Aug 5, 2026active patient affordability programsQ3 FY2026165 – 170New
Aug 5, 2026RevenueFY2026$114.00M – $117.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Paysign filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?